• LAST PRICE
    42.5500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    39.5500/ 1
  • Ask / Lots
    42.4500/ 2
  • Open / Previous Close
    44.9000 / 42.5500
  • Day Range
    Low 42.3900
    High 45.4800
  • 52 Week Range
    Low 12.4500
    High 67.2100
  • Volume
    287,304
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 44.77
TimeVolumePRAX
09:32 ET29444.9
09:34 ET315244.85
09:36 ET125244.9306
09:48 ET51645.325
09:50 ET51645.15
09:54 ET40045.29
09:56 ET30045.22
09:59 ET314844.71
10:01 ET10044.88
10:06 ET80044.68
10:08 ET20044.565
10:14 ET211144.81
10:21 ET10044.65
10:26 ET20044.6
10:28 ET30044.51
10:33 ET10044.43
10:35 ET40044.67
10:42 ET2085644.17
10:44 ET1411643.52
10:46 ET10043.615
10:48 ET163144.34
10:50 ET110044.3
10:51 ET35143.87
10:55 ET343344.255
10:57 ET10044.25
11:00 ET20044.225
11:04 ET30044.215
11:06 ET150044
11:08 ET10044
11:09 ET100043.86
11:11 ET82843.75
11:15 ET109743.75
11:18 ET25743.7
11:22 ET30043.69
11:24 ET491343.845
11:29 ET10044
11:38 ET71544
11:42 ET10044.08
11:45 ET116744.245
11:47 ET110044.43
11:49 ET10044.315
11:54 ET20044.081
12:00 ET10044.095
12:03 ET30044.08
12:07 ET70043.85
12:09 ET10043.69
12:12 ET50044.005
12:14 ET10043.74
12:23 ET200044.12
12:27 ET10044.065
12:30 ET842543.85
12:32 ET3230543.65
12:34 ET11143.7
12:36 ET40043.95
12:41 ET10043.97
12:43 ET10043.96
12:50 ET100043.905
12:54 ET219943.825
12:57 ET10043.77
01:01 ET10043.765
01:03 ET120843.6
01:06 ET10043.41
01:08 ET20043.39
01:10 ET11543.39
01:12 ET10043.22
01:14 ET220043.535
01:15 ET194043.455
01:17 ET60043.46
01:19 ET60043.465
01:21 ET20043.37
01:24 ET10043.48
01:26 ET10043.48
01:32 ET40843.48
01:33 ET20043.48
01:35 ET20043.33
01:37 ET110043.15
01:39 ET40043.27
01:42 ET10043.27
01:44 ET10043.26
01:46 ET10043.26
01:51 ET10043.255
01:53 ET50043.25
02:02 ET30043.15
02:04 ET360943.08
02:08 ET10043.08
02:13 ET53543.3
02:18 ET200243.03
02:22 ET64742.82
02:24 ET10042.8239
02:26 ET50042.8
02:29 ET110042.92
02:31 ET164242.94
02:33 ET50042.95
02:36 ET52242.95
02:38 ET27642.935
02:40 ET50042.8
02:44 ET178643.005
02:45 ET10043.01
02:47 ET42043.035
02:49 ET541543.25
02:51 ET154843.305
02:54 ET10043.15
02:56 ET97643.265
02:58 ET50043.225
03:00 ET30843.3
03:02 ET20043.325
03:03 ET70043.4
03:05 ET46843.46
03:07 ET100043.475
03:09 ET20043.48
03:12 ET10043.41
03:14 ET87443.45
03:18 ET360043.2
03:20 ET191343.255
03:21 ET20043.25
03:23 ET119943.2
03:25 ET200042.935
03:30 ET77042.75
03:32 ET30042.77
03:34 ET86142.75
03:36 ET10042.8
03:38 ET160042.84
03:39 ET60042.9
03:43 ET825443
03:45 ET50042.89
03:48 ET62242.79
03:50 ET10042.705
03:52 ET72842.39
03:54 ET252442.6
03:56 ET331542.6
03:57 ET116842.6875
03:59 ET466642.55
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
765.9M
-2.7x
---
United StatesIRON
Disc Medicine Inc
772.8M
-9.8x
---
United StatesCOGT
Cogent Biosciences Inc
757.3M
-3.2x
---
United StatesCRGX
CARGO Therapeutics Inc
789.3M
-7.2x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
793.2M
-8.8x
---
United StatesDNTH
Dianthus Therapeutics Inc
721.1M
-7.2x
---
As of 2024-05-23

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
General Counsel, Corporate Secretary
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$727.9M
Revenue (TTM)
$2.2M
Shares Outstanding
17.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.74
EPS
$-15.91
Book Value
$7.92
P/E Ratio
-2.7x
Price/Sales (TTM)
331.6
Price/Cash Flow (TTM)
---
Operating Margin
-5,930.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.